Connor, Clark & Lunn Investment Management (CC&L)’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,503
Closed -$409K 1398
2023
Q3
$409K Sell
16,503
-14,296
-46% -$360K ﹤0.01% 1069
2023
Q2
$865K Buy
+30,799
New +$765K ﹤0.01% 839
2022
Q4
Sell
-18,711
Closed -$531K 1235
2022
Q3
$531K Buy
+18,711
New +$481K ﹤0.01% 807
2020
Q4
Sell
-16,162
Closed -$105K 912
2020
Q3
$105K Buy
+16,162
New +$102K ﹤0.01% 871
2014
Q2
Sell
-21,100
Closed -$188K 541
2014
Q1
$188K Buy
21,100
+4,500
+27% +$44.3K ﹤0.01% 626
2013
Q4
$176K Buy
+16,600
New +$115K ﹤0.01% 677

Other funds holding CCRN

Connor, Clark & Lunn Investment Management (CC&L)'s CCRN Position: Q4 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Cross Country Healthcare (CCRN) in Q4 2023, closing a stake of 16,503 shares — an estimated $409K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CCRN in Q4 2013 and held it in 6 quarters. The position peaked at $865K in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Cross Country Healthcare position as of Q4 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 16,503 Cross Country Healthcare shares in Q4 2023, an estimated $409K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Cross Country Healthcare in Q4 2013 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Cross Country Healthcare position peaked at $865K in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2023, filed 9 Feb 2024.